⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of BioAgilytix Labs and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
BioAgilytix Labs
↗Durham, NC, USA
BioAgilytix is a leading global contract research organization (CRO) specializing in large-molecule bioanalysis. The company provides comprehensive bioanalytical services, including pharmacokinetics (PK), immunogenicity, biomarkers, and cell-based assays, supporting pharmaceutical and biotechnology partners through all phases of drug development—from early discovery to post-market surveillance.
With a strong focus on complex biologics, cell and gene therapies, and antibody-drug conjugates (ADCs), BioAgilytix operates state-of-the-art laboratory facilities across the United States, Europe, and Australia. The company is known for its scientist-to-scientist collaborative approach, deep regulatory expertise, and commitment to maintaining high-quality standards under GLP, GCP, and GMP environments.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:2008
Ownership:private
Status:operating
FUNDING
Stage:Private Equity-Backed
Investors:Cinven, Cobepa
PIPELINE
Modalities:Small molecule, mAb, ADC, Cell therapy, Gene therapy, Oligonucleotides
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:360biolabs
Key Partnerships:CTI (Clinical Trial and Consulting Services), Sword Bio
COMPETITION
Position:Leader
Competitors:Labcorp Drug Development, IQVIA, Charles River Laboratories, PPD (Thermo Fisher Scientific)
LEADERSHIP
Key Executives:
Euan Menzies - Chairman and CEO
Nathan Speicher - Chief Financial Officer
Dr. Linda Robbie - Chief Operating Officer
LINKS
Website:bioagilytix.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BioAgilytix Labs. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.